Jon Faiz Kayyem insider trades

Open-market stock purchases and sales by Jon Faiz Kayyem, Director at Inhibrx Biosciences, Inc, from SEC Form 4 filings since Jun 3, 2010.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -4%.

Recent trades

DateStockTradeValue
Sep 23, 2026INBX Inhibrx Biosciences, IncBought$500K
Sep 16, 2026INBX Inhibrx Biosciences, IncBought$500K
Sep 8, 2026INBX Inhibrx Biosciences, IncBought$568K
Jun 3, 2026INBX Inhibrx Biosciences, IncBought (not open market)—
Jun 3, 2026INBX Inhibrx Biosciences, IncBought (not open market)—
Jan 2, 2026BDSX Biodesix IncBought (not open market)—
Jan 2, 2026BDSX Biodesix IncBought (not open market)—

Companies traded

  • INBX Inhibrx Biosciences, Inc: 12 buys, 7 sales, last Sep 23, 2026
  • BDSX Biodesix Inc: 1 buy, last Jan 2, 2026
  • INXB Inhibrx Biosciences, Inc: other filings, last May 30, 2024
  • GNMK GenMark Diagnostics, Inc: 3 buys, 65 sales, last Feb 2, 2018

Get free alerts when Jon Faiz Kayyem files a new trade →